| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.8M | -2.8% |
| SG&A Expense | $3.6M | +2243.2% |
| Operating Income | -$5.4M | -3385.1% |
| Pre-tax Income | -$5.2M | -65.5% |
| Net Income | -$5.2M | -3106.5% |
| EPS (Basic) | -$0.66 | -1962.5% |
| EPS (Diluted) | -$0.66 | -1962.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $459K | +1247.1% |
| Current Assets | $619K | +4806.6% |
| Total Assets | $619K | +4806.6% |
| Current Liabilities | $2.1M | +635.5% |
| Total Liabilities | $2.1M | +635.5% |
| Stockholders' Equity | -$1.5M | -443.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.8M | -2531.8% |
| Financing Cash Flow | $5.2M | +2585.0% |